Notice of updates

We’ve updated our Financial Services Guide (FSG), effective 18 November 2025. By continuing to use our services after this date, you accept the revised terms.

Read FSG

icon
HALO logo
halo search icon
AbbVie, Inc.

US$223.12

Price Change Indicator
-2.96 (-1.309%)
AbbVie, Inc.
ABBV · NYS

AbbVie, Inc.

Start Trading ABBV for Free

US$223.12

Price Arrow-2.96 (-1.309%)
08/12/2025 04:10:00 PM
All-CompaniesAll-ConsensusALL-RecommendationsHALO 200HALO 500HALO AllHALO Capital Efficiency
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

AbbVie, Inc. Overview

ABBV Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Neutral

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Very Weak

Growth

Earnings

Strong

Dividends

Neutral

Quality

Capital Efficiency

Very Strong

Balance Sheet

Weak

About ABBV

icon
icon

Telephone

1.847.932.7900

icon

Address

1 North Waukegan Road, North Chicago, IL 60064-6400

Description

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

ABBV Price Chart

Key Stats

Market Cap

US$399.57B

PE

17.40

EV/EBITDA

14.8

Dividends Overview

DIV Yield

3.5%

Franking

N/A

Ex Dividend Date (est.)

16-Jan-26

Market Data

52 weeks range

Low 164.39 - 244.81

Trade Value (12mth)

US$313,501,510.00

1 week

-1.81%

1 month

3.16%

YTD

25.99%

1 year

28.04%

All time high

244.81

Key Fundamentals

EPS 3 yr Growth

-63.00%

EBITDA Margin

44.40%

Operating Cashflow

$18,806m

Free Cash Flow Return

29.50%

ROIC

6.60%

Interest Coverage

8.50

Quick Ratio

0.60

Other Data

Shares Outstanding (Fully Diluted)

1,771m

HALO Sector

Healthcare

Next Company Report Date

04-Feb-26

Next Ex Dividend Date

16-Jan-26

Next Dividend Pay Date

17-Feb-26

Reporting Currency

USD

Short Sell (% of issue)

0.00

ABBV Announcements

Latest Announcements

DateAnnouncements
04 November 25
31 October 25
31 October 25
03 October 25
03 October 25

ABBV Fundamentals

Per Share Records

Historical data

Forecast data

USD2020202120222023202220232024202520262027
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock6.652.732.4locklocklock
EPS (Fully Diluted)
 $locklocklocklock6.632.722.39locklocklock
Growth
 %locklocklocklock2.7-59-12.1locklocklock
PE
 Xlocklocklocklock10.515.117.4locklocklock
EV/EBITDA
 Xlocklocklocklock10.213.514.8locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

16-Jan-26

DIV Yield

3.5%

Franking Level

N/A

DPSg

5%

Quality Yield

lock

Falling Divs over next 2

lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Want to learn more?Frequently asked questions.
What is the current share price of AbbVie, Inc. (ABBV:NYS)?
Halo FAQ
The current share price of AbbVie, Inc. (ABBV:NYS) is USD$223.12.
What is the 52-week high share price for AbbVie, Inc. (ABBV:NYS)?
Halo FAQ
The 52-week high share price for AbbVie, Inc. (ABBV:NYS) is USD$244.81.
What is the 52-week low share price for AbbVie, Inc. (ABBV:NYS)?
Halo FAQ
The 52-week low share price for AbbVie, Inc. (ABBV:NYS) is USD$164.39.
What is the dividend yield for AbbVie, Inc. (ABBV:NYS)?
Halo FAQ
The current TTM dividend payout for AbbVie, Inc. (ABBV:NYS) is 3.50.
What was AbbVie, Inc. (ABBV:NYS) last dividend payment?
Halo FAQ
The last dividend payment of AbbVie, Inc. (ABBV:NYS) is USD$1.64.
What is the franking level for AbbVie, Inc. (ABBV:NYS)?
Halo FAQ
AbbVie, Inc. (ABBV:NYS) has a franking level of 0.00%.
In which sector is AbbVie, Inc. (ABBV:NYS) classified?
Halo FAQ
AbbVie, Inc. (ABBV:NYS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for AbbVie, Inc. (ABBV:NYS)?
Halo FAQ
The current P/E ratio for AbbVie, Inc. (ABBV:NYS) is 17.40.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial